ロード中...
Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma
Glioblastoma (GBM) is one of the most devastating brain tumors with poor prognosis and high mortality. Although radical surgical treatment with subsequent radiation and chemotherapy can improve the survival, the efficacy of such regimens is insufficient because the GBM cells can spread and destroy n...
保存先:
| 出版年: | Curr Pharm Des |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Bentham Science Publishers
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5470055/ https://ncbi.nlm.nih.gov/pubmed/28302023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1381612823666170316125402 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|